cannabidiol (CBD) in Focus Posted on 15 Jan 13:22

cannabidiol (CBD)

This is, interestingly, not as standard practice moved as cannabis ingredient THC into the center, but the cannabidiol (CBD).
Tetrahydrocannabinol (THC) is always shown as the main active ingredient in cannabis. But cannabis contains 66 different cannabinoids with different modes of action.
For THC the therapeutic use in some situations is difficult by the intoxicating effect. In addition, do not reach all patients with a pure THC preparation - in Switzerland as dronabinol in trade - a satisfactory treatment outcome.
Unlike THC CBD developed no psychoactive “high.” effect.
On the contrary, according to recent studies, CBD should neutralize the psychoactive effect of the THC's or at least slow down. Moreover, it should also have a cancer and anti-inflammatory effect. Already known for some time was its anticonvulsant, anxiolytic, and nausea-relieving effect. In addition, CBD is only slightly toxic and has few side effects, emphasizes the pharmacist Rudolf cautery, a specialist in cannabis at the University of Bern.
For a long time the research around the use of cannabis in medicine, according to cautery has mainly focused on the active ingredient THC. Cannabinoids have been used primarily to treat neurological disorders such as multiple sclerosis or epilepsy, against the side effects of chemotherapy or for chronic pain. The discovery of the CBD and its potency of cannabis gave new impetus to international research, says branding iron. For the natural remedies cannabis thereby always open new research approaches, such as the application in breast cancer, or psychosis. Medicinalcannabis has become increasingly important in recent years.

One consequence of this cannabis research is the introduction of Sativex - a drug with a combination of THC and CBD, may contribute to relief of pain and discomfort in multiple sclerosis.